Inventor · disambiguated record
Tine Bryan Stensbol
Also filed as: STENSBOL TINE B · STENSBOL TINE BRYAN
8 granted patents·6 pending applications·92 citations·filing 2004–2016
89Inventor score
Top patents by PatentIndex Score
14 records- 0194US8722684B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentBANG-ANDERSEN BENNY·Filed 2007·Granted May 13, 2014·31 cites·8 claims
- 0292US9125908B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·11 cites·10 claims
- 0391US9125909B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·9 cites·11 claims
- 0491US9125910B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·9 cites·10 claims
- 0586US8299095B2Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition and uses thereofBANG-ANDERSEN BENNY·Filed 2007·Granted Oct 30, 2012·8 cites·18 claims
- 0682US9315459B2Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidineLUNDBECK & CO AS H·Filed 2014·Granted Apr 19, 2016·4 cites·17 claims
- 0778US8664225B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognitionMOORE NICHOLAS·Filed 2008·Granted Mar 4, 2014·7 cites·5 claims
- 0878US7732463B24-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitorsLUNDBECK & CO AS H·Filed 2004·Granted Jun 8, 2010·13 cites·16 claims
- 0956US2013190352A1Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic painLUNDBECK & CO AS H·Filed 2012·Application pending·0 cites
- 1053US2010144788A14- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depressionLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
- 1152US2017037006A1Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidineH LUNDBECK AS·Filed 2016·Application pending·0 cites
- 1251US2011039890A14-[2,3-Difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidineLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
- 1345US2009054510A1Method for identifying compounds for the treatment of depressionLUNDBECK & CO AS H·Filed 2007·Application pending·0 cites
- 1445US2010105730A1Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidineLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →